We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
256 hedge funds and large institutions have $2.4B invested in Acadia Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 90 increasing their positions, 81 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
151% more call options, than puts
Call options by funds: $16M | Put options by funds: $6.39M
11% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 81
3% less funds holding
Funds holding: 264 → 256 (-8)
3.31% less ownership
Funds ownership: 97.56% → 94.25% (-3.3%)
8% less capital invested
Capital invested by funds: $2.62B → $2.4B (-$214M)
17% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 42
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
256
Holders Change
-8
Holders Change %
-3.03%
% of All Funds
3.68%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
35
Increased
90
Reduced
81
Closed
42
Calls
$16M
Puts
$6.39M
Net Calls
+$9.63M
Net Calls Change
+$2.28M
Top Buyers
| 1 |
Man Group
London,
United Kingdom
|
+$20.3M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$15.4M |
| 3 |
O
OrbiMed
New York
|
+$12.8M |
| 4 |
Two Sigma Investments
New York
|
+$12.7M |
| 5 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
+$12.5M |
